What type of study is this?

September 18, 2025Current OncologyOpen Access

Renal Cell Carcinoma: Prognosis in the Era of Targeted Therapy

View Full Paper

Ask AI

Bookmark

Relative survival rates increased for low, intermediate, and high-risk renal cell carcinoma groups.
The proportion of metastatic renal cell carcinoma cases decreased significantly over the study periods.
High-risk clear cell renal carcinoma patients benefited from recent drug treatment advancements.
Earlier diagnosis contributes positively to the prognosis of the majority of renal cell carcinoma patients.

No takes yet. Share an insight, caveat, or question.

Observational analysis identifies improved prognosis in renal cell carcinoma patients, highlighting the impact of targeted therapies.

Halfter et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark